{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:37:03Z","timestamp":1790026623708,"version":"4.0.1"},"update-to":[{"DOI":"10.1371\/journal.pbio.3002355","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000}}],"reference-count":86,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T00:00:00Z","timestamp":1699488000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The German-Israel Foundation","award":["I-1459-412.13\/2018"],"award-info":[{"award-number":["I-1459-412.13\/2018"]}]}],"content-domain":{"domain":["www.plosbiology.org"],"crossmark-restriction":false},"short-container-title":["PLoS Biol"],"abstract":"<jats:p>The introduction of premature termination codons (PTCs), as a result of splicing defects, insertions, deletions, or point mutations (also termed nonsense mutations), lead to numerous genetic diseases, ranging from rare neuro-metabolic disorders to relatively common inheritable cancer syndromes and muscular dystrophies. Over the years, a large number of studies have demonstrated that certain antibiotics and other synthetic molecules can act as PTC suppressors by inducing readthrough of nonsense mutations, thereby restoring the expression of full-length proteins. Unfortunately, most PTC readthrough-inducing agents are toxic, have limited effects, and cannot be used for therapeutic purposes. Thus, further efforts are required to improve the clinical outcome of nonsense mutation suppressors. Here, by focusing on enhancing readthrough of pathogenic nonsense mutations in the <jats:italic>adenomatous polyposis coli<\/jats:italic> (APC) tumor suppressor gene, we show that disturbing the protein translation initiation complex, as well as targeting other stages of the protein translation machinery, enhances both antibiotic and non-antibiotic-mediated readthrough of nonsense mutations. These findings strongly increase our understanding of the mechanisms involved in nonsense mutation readthrough and facilitate the development of novel therapeutic targets for nonsense suppression to restore protein expression from a large variety of disease-causing mutated transcripts.<\/jats:p>","DOI":"10.1371\/journal.pbio.3002355","type":"journal-article","created":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T18:53:37Z","timestamp":1699556017000},"page":"e3002355","update-policy":"https:\/\/doi.org\/10.1371\/journal.pbio.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Nonsense mutation suppression is enhanced by targeting different stages of the protein synthesis process"],"prefix":"10.1371","volume":"21","author":[{"given":"Amnon","family":"Wittenstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Caspi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ido","family":"Rippin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orna","family":"Elroy-Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagit","family":"Eldar-Finkelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Thoms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4216-2425","authenticated-orcid":true,"given":"Rina","family":"Rosin-Arbesfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,11,9]]},"reference":[{"issue":"10","key":"pbio.3002355.ref001","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/hmg\/8.10.1893","article-title":"Nonsense-mediated mRNA decay in health and disease","volume":"8","author":"PA Frischmeyer","year":"1999","journal-title":"Hum Mol Genet"},{"issue":"8","key":"pbio.3002355.ref002","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/humu.20763","article-title":"A meta-analysis of nonsense mutations causing human genetic disease","volume":"29","author":"M Mort","year":"2008","journal-title":"Hum Mutat"},{"issue":"1","key":"pbio.3002355.ref003","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s10020-018-0024-7","article-title":"Advances in therapeutic use of a drug-stimulated translational readthrough of premature termination codons","volume":"24","author":"M Dabrowski","year":"2018","journal-title":"Mol Med"},{"issue":"12","key":"pbio.3002355.ref004","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21124394","article-title":"Suppression of Nonsense Mutations by New Emerging Technologies.","volume":"21","author":"P Morais","year":"2020","journal-title":"Int J Mol Sci."},{"issue":"17","key":"pbio.3002355.ref005","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.1093\/nar\/13.17.6265","article-title":"Suppression of a nonsense mutation in mammalian cells in vivo by the aminoglycoside antibiotics G-418 and paromomycin","volume":"13","author":"JF Burke","year":"1985","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"pbio.3002355.ref006","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1261\/rna.805208","article-title":"Eukaryotic ribosomal RNA determinants of aminoglycoside resistance and their role in translational fidelity","volume":"14","author":"H Fan-Minogue","year":"2008","journal-title":"RNA"},{"issue":"51","key":"pbio.3002355.ref007","doi-asserted-by":"crossref","first-page":"E10899","DOI":"10.1073\/pnas.1715501114","article-title":"Aminoglycoside interactions and impacts on the eukaryotic ribosome","volume":"114","author":"I Prokhorova","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"pbio.3002355.ref008","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/hmg\/ddx409","article-title":"Aminoglycoside-mediated promotion of translation readthrough occurs through a non-stochastic mechanism that competes with translation termination","volume":"27","author":"HM Chowdhury","year":"2018","journal-title":"Hum Mol Genet"},{"issue":"4","key":"pbio.3002355.ref009","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1074\/jbc.M113.533588","article-title":"Designer aminoglycosides that selectively inhibit cytoplasmic rather than mitochondrial ribosomes show decreased ototoxicity: a strategy for the treatment of genetic diseases","volume":"289","author":"E Shulman","year":"2014","journal-title":"J Biol Chem"},{"issue":"4","key":"pbio.3002355.ref010","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1165\/rcmb.2013-0282OC","article-title":"Synthetic aminoglycosides efficiently suppress cystic fibrosis transmembrane conductance regulator nonsense mutations and are enhanced by ivacaftor","volume":"50","author":"X Xue","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"key":"pbio.3002355.ref011","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1749-6632.2012.06467.x","article-title":"SMRT compounds correct nonsense mutations in primary immunodeficiency and other genetic models","volume":"1250","author":"RA Gatti","year":"2012","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"pbio.3002355.ref012","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1073\/pnas.0711795105","article-title":"PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-G542X nonsense allele in a CF mouse model","volume":"105","author":"M Du","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"pbio.3002355.ref013","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/gut.2008.169805","article-title":"Restoration of APC gene function in colorectal cancer cells by aminoglycoside- and macrolide-induced read-through of premature termination codons","volume":"59","author":"A Zilberberg","year":"2010","journal-title":"Gut"},{"issue":"5","key":"pbio.3002355.ref014","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/jb\/mvg203","article-title":"Negamycin restores dystrophin expression in skeletal and cardiac muscles of mdx mice","volume":"134","author":"M Arakawa","year":"2003","journal-title":"J Biochem"},{"issue":"4","key":"pbio.3002355.ref015","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.molmed.2023.01.004","article-title":"Readthrough compounds for nonsense mutations: bridging the translational gap","volume":"29","author":"S Spelier","year":"2023","journal-title":"Trends Mol Med"},{"issue":"Suppl 2","key":"pbio.3002355.ref016","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1023\/A:1012419823739","article-title":"Is genotype determination useful in predicting the clinical phenotype in lysosomal storage diseases?","volume":"24","author":"I. Maire","year":"2001","journal-title":"J Inherit Metab Dis"},{"issue":"11","key":"pbio.3002355.ref017","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1016\/j.bmc.2010.03.060","article-title":"Repairing faulty genes by aminoglycosides: development of new derivatives of geneticin (G418) with enhanced suppression of diseases-causing nonsense mutations.","volume":"18","author":"I Nudelman","year":"2010","journal-title":"Bioorg Med Chem"},{"issue":"4","key":"pbio.3002355.ref018","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00109-015-1364-1","article-title":"A flow cytometry-based reporter assay identifies macrolide antibiotics as nonsense mutation read-through agents","volume":"94","author":"M Caspi","year":"2016","journal-title":"J Mol Med (Berl)."},{"issue":"14","key":"pbio.3002355.ref019","doi-asserted-by":"crossref","first-page":"6583","DOI":"10.1093\/nar\/gkw638","article-title":"Novel small molecules potentiate premature termination codon readthrough by aminoglycosides","volume":"44","author":"A Baradaran-Heravi","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"pbio.3002355.ref020","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/978-1-4419-1145-2_8","article-title":"APC and its modifiers in colon cancer","volume":"656","author":"LN Kwong","year":"2009","journal-title":"Adv Exp Med Biol"},{"issue":"6392","key":"pbio.3002355.ref021","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/359235a0","article-title":"APC mutations occur early during colorectal tumorigenesis","volume":"359","author":"SM Powell","year":"1992","journal-title":"Nature"},{"issue":"8","key":"pbio.3002355.ref022","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw332","article-title":"Multiple Roles of APC and its Therapeutic Implications in Colorectal Cancer","volume":"109","author":"L Zhang","year":"2017","journal-title":"J Natl Cancer Inst"},{"issue":"22","key":"pbio.3002355.ref023","doi-asserted-by":"crossref","first-page":"5618","DOI":"10.1002\/j.1460-2075.1995.tb00249.x","article-title":"The tumour suppressor gene product APC blocks cell cycle progression from G0\/G1 to S phase.","volume":"14","author":"GH Baeg","year":"1995","journal-title":"EMBO J."},{"issue":"4","key":"pbio.3002355.ref024","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/35070123","article-title":"A role for the Adenomatous Polyposis Coli protein in chromosome segregation","volume":"3","author":"KB Kaplan","year":"2001","journal-title":"Nat Cell Biol"},{"issue":"3","key":"pbio.3002355.ref025","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1091\/mbc.e06-03-0179","article-title":"Lack of adenomatous polyposis coli protein correlates with a decrease in cell migration and overall changes in microtubule stability","volume":"18","author":"K Kroboth","year":"2007","journal-title":"Mol Biol Cell"},{"key":"pbio.3002355.ref026","first-page":"150","article-title":"The adenomatous polyposis coli protein 30 years on","author":"J Abbott","year":"2023","journal-title":"Semin Cell Dev Biol"},{"issue":"1","key":"pbio.3002355.ref027","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/nar\/26.1.269","article-title":"APC gene: database of germline and somatic mutations in human tumors and cell lines","volume":"26","author":"P Laurent-Puig","year":"1998","journal-title":"Nucleic Acids Res"},{"key":"pbio.3002355.ref028","doi-asserted-by":"crossref","first-page":"686984","DOI":"10.1155\/2014\/686984","article-title":"mTOR Signaling in Protein Translation Regulation: Implications in Cancer Genesis and Therapeutic Interventions","volume":"2014","author":"M Showkat","year":"2014","journal-title":"Mol Biol Int"},{"issue":"12","key":"pbio.3002355.ref029","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s00109-019-01847-0","article-title":"Serum starvation enhances nonsense mutation readthrough","volume":"97","author":"A Wittenstein","year":"2019","journal-title":"J Mol Med (Berl)."},{"issue":"8","key":"pbio.3002355.ref030","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1172\/JCI200317222","article-title":"Loss of Tsc1\/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR","volume":"112","author":"H Zhang","year":"2003","journal-title":"J Clin Invest"},{"issue":"1","key":"pbio.3002355.ref031","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1038\/s41467-021-24575-x","article-title":"A small molecule that induces translational readthrough of CFTR nonsense mutations by eRF1 depletion.","volume":"12","author":"J Sharma","year":"2021","journal-title":"Nat Commun."},{"issue":"1","key":"pbio.3002355.ref032","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1038\/s41598-020-59899-z","article-title":"APC controls Wnt-induced \u03b2-catenin destruction complex recruitment in human colonocytes.","volume":"10","author":"TW Parker","year":"2020","journal-title":"Sci Rep"},{"issue":"23","key":"pbio.3002355.ref033","article-title":"Oxidative Distress Induces Wnt\/beta-Catenin Pathway Modulation in Colorectal Cancer Cells: Perspectives on APC Retained Functions.","volume":"13","author":"D Catalano T","year":"2021","journal-title":"Cancers (Basel)."},{"issue":"5","key":"pbio.3002355.ref034","doi-asserted-by":"crossref","first-page":"10411","DOI":"10.3390\/ijms160510411","article-title":"TCF4 Is a Molecular Target of Resveratrol in the Prevention of Colorectal Cancer.","volume":"16","author":"JB Jeong","year":"2015","journal-title":"Int J Mol Sci"},{"issue":"5307","key":"pbio.3002355.ref035","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1126\/science.275.5307.1787","article-title":"Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC","volume":"275","author":"PJ Morin","year":"1997","journal-title":"Science"},{"issue":"2","key":"pbio.3002355.ref036","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/hmg\/ddl464","article-title":"Truncated APC regulates the transcriptional activity of beta-catenin in a cell cycle dependent manner","volume":"16","author":"J Schneikert","year":"2007","journal-title":"Hum Mol Genet"},{"issue":"26","key":"pbio.3002355.ref037","doi-asserted-by":"crossref","first-page":"17751","DOI":"10.1074\/jbc.M600831200","article-title":"Adenomatous polyposis coli (APC) differentially regulates beta-catenin phosphorylation and ubiquitination in colon cancer cells.","volume":"281","author":"J Yang","year":"2006","journal-title":"J Biol Chem"},{"issue":"7","key":"pbio.3002355.ref038","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1073\/pnas.92.7.3046","article-title":"Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein.","volume":"92","author":"S Munemitsu","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pbio.3002355.ref039","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejca.2022.06.031","article-title":"Tankyrase-selective inhibitor STP1002 shows preclinical antitumour efficacy without on-target toxicity in the gastrointestinal tract","volume":"173","author":"DY Kim","year":"2022","journal-title":"Eur J Cancer"},{"issue":"7","key":"pbio.3002355.ref040","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1073\/pnas.97.7.3352","article-title":"APC mutations in sporadic colorectal tumors: A mutational \u201chotspot\u201d and interdependence of the \u201ctwo hits\u201d.","volume":"97","author":"AJ Rowan","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"pbio.3002355.ref041","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1158\/1535-7163.MCT-06-0433","article-title":"Mutation analysis of 24 known cancer genes in the NCI-60 cell line set","volume":"5","author":"ON Ikediobi","year":"2006","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"pbio.3002355.ref042","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s001090050098","article-title":"Molecular analysis of the adenomatous polyposis coli gene in sarcomas, hematological malignancies and noncolonic, neoplastic tissues","volume":"75","author":"M Wada","year":"1997","journal-title":"J Mol Med (Berl)."},{"issue":"12","key":"pbio.3002355.ref043","doi-asserted-by":"crossref","first-page":"110538","DOI":"10.1016\/j.celrep.2022.110538","article-title":"Neddylation is essential for beta-catenin degradation in Wnt signaling pathway","volume":"38","author":"B Wang","year":"2022","journal-title":"Cell Rep"},{"key":"pbio.3002355.ref044","article-title":"FAK\/PYK2 promotes the Wnt\/beta-catenin pathway and intestinal tumorigenesis by phosphorylating GSK3beta.","volume":"4","author":"C Gao","year":"2015","journal-title":"Elife."},{"issue":"2","key":"pbio.3002355.ref045","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s11033-022-08084-8","article-title":"Evaluation of osteogenic induction potency of miR-27a-3p in adipose tissue-derived human mesenchymal stem cells (AD-hMSCs).","volume":"50","author":"F Arab","year":"2023","journal-title":"Mol Biol Rep"},{"issue":"6","key":"pbio.3002355.ref046","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/15384101.2016.1151581","article-title":"4E-BP1, a multifactor regulated multifunctional protein","volume":"15","author":"X Qin","year":"2016","journal-title":"Cell Cycle"},{"issue":"5","key":"pbio.3002355.ref047","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrm2672","article-title":"Molecular mechanisms of mTOR-mediated translational control","volume":"10","author":"XM Ma","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"pbio.3002355.ref048","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1083\/jcb.201306041","article-title":"Where is mTOR and what is it doing there?","volume":"203","author":"C Betz","year":"2013","journal-title":"J Cell Biol"},{"issue":"2","key":"pbio.3002355.ref049","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.3390\/ijms13021886","article-title":"The mTOR signalling pathway in human cancer","volume":"13","author":"H P\u00f3pulo","year":"2012","journal-title":"Int J Mol Sci"},{"key":"pbio.3002355.ref050","first-page":"5","article-title":"Dynamics of mTORC1 activation in response to amino acids","author":"M Manifava","year":"2016","journal-title":"Elife"},{"issue":"21","key":"pbio.3002355.ref051","doi-asserted-by":"crossref","first-page":"13571","DOI":"10.1073\/pnas.202476899","article-title":"Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling.","volume":"99","author":"AR Tee","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"pbio.3002355.ref052","doi-asserted-by":"crossref","first-page":"8023","DOI":"10.1074\/jbc.M900301200","article-title":"An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1","volume":"284","author":"CC Thoreen","year":"2009","journal-title":"J Biol Chem"},{"issue":"6","key":"pbio.3002355.ref053","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1093\/nar\/gkw1109","article-title":"Modulation of nonsense mediated decay by rapamycin","volume":"45","author":"RT Martinez-Nunez","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"pbio.3002355.ref054","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.18632\/oncotarget.13772","article-title":"Inhibiting the MNK-eIF4E-\u03b2-catenin axis increases the responsiveness of aggressive breast cancer cells to chemotherapy","volume":"8","author":"Z Li","year":"2017","journal-title":"Oncotarget"},{"issue":"8","key":"pbio.3002355.ref055","doi-asserted-by":"crossref","first-page":"e0136746","DOI":"10.1371\/journal.pone.0136746","article-title":"Ribavirin Inhibits the Activity of mTOR\/eIF4E, ERK\/Mnk1\/eIF4E Signaling Pathway and Synergizes with Tyrosine Kinase Inhibitor Imatinib to Impair Bcr-Abl Mediated Proliferation and Apoptosis in Ph+ Leukemia.","volume":"10","author":"F Shi","year":"2015","journal-title":"PLoS ONE"},{"issue":"15","key":"pbio.3002355.ref056","doi-asserted-by":"crossref","first-page":"6539","DOI":"10.1128\/MCB.24.15.6539-6549.2004","article-title":"Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development","volume":"24","author":"T Ueda","year":"2004","journal-title":"Mol Cell Biol"},{"issue":"21","key":"pbio.3002355.ref057","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.1128\/MCB.00760-07","article-title":"Inhibition of mammalian target of rapamycin induces phosphatidylinositol 3-kinase-dependent and Mnk-mediated eukaryotic translation initiation factor 4E phosphorylation","volume":"27","author":"X Wang","year":"2007","journal-title":"Mol Cell Biol"},{"issue":"16","key":"pbio.3002355.ref058","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1101\/gad.1212704","article-title":"Upstream and downstream of mTOR","volume":"18","author":"N Hay","year":"2004","journal-title":"Genes Dev"},{"issue":"2","key":"pbio.3002355.ref059","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.cell.2006.11.046","article-title":"Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G","volume":"128","author":"NJ Moerke","year":"2007","journal-title":"Cell"},{"issue":"4","key":"pbio.3002355.ref060","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/fcp.12759","article-title":"Inhibition MNK-eIF4E-beta-catenin preferentially sensitizes gastric cancer to chemotherapy","volume":"36","author":"X Yang","year":"2022","journal-title":"Fundam Clin Pharmacol"},{"issue":"48","key":"pbio.3002355.ref061","doi-asserted-by":"crossref","first-page":"6416","DOI":"10.1038\/sj.onc.1209888","article-title":"mTOR, translation initiation and cancer","volume":"25","author":"Y Mamane","year":"2006","journal-title":"Oncogene"},{"issue":"22","key":"pbio.3002355.ref062","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1128\/MCB.01035-14","article-title":"Eukaryotic elongation factor 2 kinase activity is controlled by multiple inputs from oncogenic signaling","volume":"34","author":"X Wang","year":"2014","journal-title":"Mol Cell Biol"},{"issue":"5","key":"pbio.3002355.ref063","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.cub.2019.01.029","article-title":"Regulation of the Elongation Phase of Protein Synthesis Enhances Translation Accuracy and Modulates Lifespan","volume":"29","author":"J Xie","year":"2019","journal-title":"Curr Biol"},{"issue":"51","key":"pbio.3002355.ref064","doi-asserted-by":"crossref","first-page":"43951","DOI":"10.1074\/jbc.M111.301291","article-title":"1-Benzyl-3-cetyl-2-methylimidazolium iodide (NH125) induces phosphorylation of eukaryotic elongation factor-2 (eEF2): a cautionary note on the anticancer mechanism of an eEF2 kinase inhibitor.","volume":"286","author":"Z Chen","year":"2011","journal-title":"J Biol Chem"},{"issue":"4","key":"pbio.3002355.ref065","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/nat.2019.0779","article-title":"Targeting Translation Termination Machinery with Antisense Oligonucleotides for Diseases Caused by Nonsense Mutations.","volume":"29","author":"L Huang","year":"2019","journal-title":"Nucleic Acid Ther."},{"issue":"7","key":"pbio.3002355.ref066","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1021\/acschembio.0c00055","article-title":"Release Factor Inhibiting Antimicrobial Peptides Improve Nonstandard Amino Acid Incorporation in Wild-type Bacterial Cells.","volume":"15","author":"E Kuru","year":"2020","journal-title":"ACS Chem Biol"},{"issue":"9","key":"pbio.3002355.ref067","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/nsmb.3439","article-title":"An antimicrobial peptide that inhibits translation by trapping release factors on the ribosome","volume":"24","author":"T Florin","year":"2017","journal-title":"Nat Struct Mol Biol"},{"key":"pbio.3002355.ref068","article-title":"Dynamics of ribosomes and release factors during translation termination in E.","volume":"7","author":"S Adio","year":"2018","journal-title":"coli. Elife"},{"issue":"1","key":"pbio.3002355.ref069","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1038\/s41467-018-05465-1","article-title":"Visualization of translation termination intermediates trapped by the Apidaecin 137 peptide during RF3-mediated recycling of RF1.","volume":"9","author":"M Graf","year":"2018","journal-title":"Nat Commun."},{"issue":"4","key":"pbio.3002355.ref070","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.molcel.2013.12.028","article-title":"Optimal translational termination requires C4 lysyl hydroxylation of eRF1","volume":"53","author":"T Feng","year":"2014","journal-title":"Mol Cell"},{"issue":"4","key":"pbio.3002355.ref071","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/ijc.32557","article-title":"Resorting the function of the colorectal cancer gatekeeper adenomatous polyposis coli","volume":"146","author":"R Kariv","year":"2020","journal-title":"Int J Cancer"},{"issue":"9","key":"pbio.3002355.ref072","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1164\/rccm.201601-0154OC","article-title":"Discovery of Clinically Approved Agents That Promote Suppression of Cystic Fibrosis Transmembrane Conductance Regulator Nonsense Mutations","volume":"194","author":"V Mutyam","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"pbio.3002355.ref073","doi-asserted-by":"crossref","DOI":"10.3390\/ph14080785","article-title":"Ataluren-Promising Therapeutic Premature Termination Codon Readthrough Frontrunner.","volume":"14","author":"S. Michorowska","year":"2021","journal-title":"Pharmaceuticals (Basel)."},{"issue":"4","key":"pbio.3002355.ref074","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nm0496-467","article-title":"Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations","volume":"2","author":"M Howard","year":"1996","journal-title":"Nat Med"},{"issue":"7","key":"pbio.3002355.ref075","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1017\/S1355838200000716","article-title":"Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system","volume":"6","author":"M Manuvakhova","year":"2000","journal-title":"RNA"},{"key":"pbio.3002355.ref076","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.52611","article-title":"Stop codon context influences genome-wide stimulation of termination codon readthrough by aminoglycosides.","volume":"9","author":"JR Wangen","year":"2020","journal-title":"Elife"},{"issue":"1","key":"pbio.3002355.ref077","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13024-020-00369-5","article-title":"Premature termination codon readthrough upregulates progranulin expression and improves lysosomal function in preclinical models of GRN deficiency.","volume":"15","author":"J Frew","year":"2020","journal-title":"Mol Neurodegener."},{"issue":"8","key":"pbio.3002355.ref078","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/cpdd.647","article-title":"Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of ELX-02, a Potential Treatment for Genetic Disorders Caused by Nonsense Mutations, in Healthy Volunteers.","volume":"8","author":"A Leubitz","year":"2019","journal-title":"Clin Pharmacol Drug Dev"},{"issue":"44","key":"pbio.3002355.ref079","doi-asserted-by":"crossref","first-page":"12508","DOI":"10.1073\/pnas.1605336113","article-title":"Ataluren stimulates ribosomal selection of near-cognate tRNAs to promote nonsense suppression","volume":"113","author":"B Roy","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7140","key":"pbio.3002355.ref080","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nature05756","article-title":"PTC124 targets genetic disorders caused by nonsense mutations","volume":"447","author":"EM Welch","year":"2007","journal-title":"Nature"},{"issue":"2","key":"pbio.3002355.ref081","doi-asserted-by":"crossref","first-page":"232","DOI":"10.4161\/15384101.2014.977096","article-title":"The synergistic inhibition of breast cancer proliferation by combined treatment with 4EGI-1 and MK2206","volume":"14","author":"H Wang","year":"2015","journal-title":"Cell Cycle"},{"issue":"30","key":"pbio.3002355.ref082","doi-asserted-by":"crossref","first-page":"E4036","DOI":"10.1073\/pnas.1512118112","article-title":"Molecular mechanism of the dual activity of 4EGI-1: Dissociating eIF4G from eIF4E but stabilizing the binding of unphosphorylated 4E-BP1","volume":"112","author":"N Sekiyama","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"pbio.3002355.ref083","doi-asserted-by":"crossref","first-page":"5677","DOI":"10.1093\/nar\/gki862","article-title":"Crystal structures of complexes between aminoglycosides and decoding A site oligonucleotides: role of the number of rings and positive charges in the specific binding leading to miscoding","volume":"33","author":"B Francois","year":"2005","journal-title":"Nucleic Acids Res"},{"issue":"7519","key":"pbio.3002355.ref084","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nature13737","article-title":"Structural basis for the inhibition of the eukaryotic ribosome","volume":"513","author":"N Garreau de Loubresse","year":"2014","journal-title":"Nature"},{"issue":"6","key":"pbio.3002355.ref085","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1261\/rna.5280103","article-title":"Stop codon suppression via inhibition of eRF1 expression","volume":"9","author":"J Carnes","year":"2003","journal-title":"RNA"},{"issue":"5","key":"pbio.3002355.ref086","doi-asserted-by":"crossref","first-page":"e0216423","DOI":"10.1371\/journal.pone.0216423","article-title":"The antimalarial drug mefloquine enhances TP53 premature termination codon readthrough by aminoglycoside G418.","volume":"14","author":"MW Ferguson","year":"2019","journal-title":"PLoS ONE."}],"updated-by":[{"DOI":"10.1371\/journal.pbio.3002355","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000}},{"DOI":"10.1371\/journal.pbio.3002524","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T00:00:00Z","timestamp":1707868800000}}],"container-title":["PLOS Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pbio.3002355","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T19:31:53Z","timestamp":1701199913000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pbio.3002355"}},"subtitle":[],"editor":[{"given":"Jeff","family":"Coller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,11,9]]},"references-count":86,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,11,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pbio.3002355","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pbio.3002355","asserted-by":"object"}],"correction":[{"id-type":"doi","id":"10.1371\/journal.pbio.3002524","asserted-by":"object"}]},"ISSN":["1545-7885"],"issn-type":[{"value":"1545-7885","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,9]]}}}